Increasing incidence of hypoglycemic coma in children with IDDM

Area of Science:

• Pediatric Endocrinology
• Metabolic Disorders
• Diabetes Mellitus Research

Background:

• Insulin-dependent diabetes mellitus (IDDM) management in children requires balancing glycemic control with hypoglycemia risk.
• Understanding risk factors for severe hypoglycemia, such as hypoglycemic coma, is crucial for optimizing treatment strategies.
• Residual beta-cell function and glycemic markers like HbA1 levels are potential indicators of hypoglycemia risk.

Purpose of the Study:

• To determine the incidence of hypoglycemic coma in children with IDDM over an 8-year period.
• To identify residual beta-cell function, HbA1 levels, and other variables as risk factors for hypoglycemic coma.
• To investigate the impact of intensified diabetes management on hypoglycemia incidence.

Main Methods:

• Prospective study of 155 children with IDDM (age < 16) over 816.6 person-years.
• Standardized questionnaires and monthly clinical/laboratory assessments, including C-peptide and HbA1 levels.
• Case-control analysis matched for diabetes duration, using logistic regression to calculate odds ratios.

Main Results:

• Yearly incidence of hypoglycemic coma increased significantly from 4.4/100 person-yr (years 1-4) to 7.4/100 person-yr (years 5-8).
• This increase coincided with intensified insulin therapy, more daily injections, and lower mean HbA1 levels.
• Absent residual beta-cell function (OR 7.8) and near-normal HbA1 levels (OR 4.5) were significant risk factors for hypoglycemic coma.

Conclusions:

• Improved glycemic control in pediatric IDDM may paradoxically increase severe hypoglycemia incidence.
• For children with recurrent hypoglycemic coma and undetectable C-peptide, less stringent glycemic targets might be safer.
• Individualized treatment approaches are necessary to mitigate hypoglycemia risk while managing diabetes.